dronabinol has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, AJ; Kogan, M; Momeni, K | 1 |
| Wilkinson, JD; Williamson, EM | 1 |
1 review(s) available for dronabinol and Psoriasis
| Article | Year |
|---|---|
Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature.
Topics: Administration, Topical; Adult; Dronabinol; Facial Dermatoses; Humans; Male; Psoriasis; Scalp Dermatoses; Skin Cream; Treatment Outcome | 2020 |
1 other study(ies) available for dronabinol and Psoriasis
| Article | Year |
|---|---|
Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Topics: Analgesics, Non-Narcotic; Cell Division; Cell Line; Dose-Response Relationship, Drug; Dronabinol; Humans; Keratinocytes; Psoriasis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |